Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 53 Show results per page	View Search Criteria \| Help With Results


1.		Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Biomarker/Laboratory analysis, Treatment				Active				18 to 85				Other				20050113 NCT00243685


2.		A Study of AVE8062 in Advanced-Stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				EFC10145 AVE8062, EudraCT 2007-003592-39, NCT00699517

Last Modified: 10/23/2008 First Published: 12/23/2003


3.		Phase III Study of Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiotherapy in Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 50				NCI				COG-ARST0331 NCT00075582, ARST0331


4.		A Study to Provide Access to Trabectedin in Patients With Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				CR003583 SAR-3002, ET743SAR3002, NCT00210665

Last Modified: 10/23/2008 First Published: 6/22/2006


5.		Phase III Study of Risk-Based Therapy Comprising Observation Only, Adjuvant Radiotherapy, or Adjuvant Chemoradiotherapy or Neoadjuvant Chemoradiotherapy, Surgery, and Adjuvant Chemotherapy With or Without Radiotherapy in Young Patients With Non-Rhabdomyosarcoma Soft Tissue Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 30 at diagnosis				NCI				COG-ARST0332 ARST0332, NCT00346164

Last Modified: 10/17/2008 First Published: 7/14/2006


6.		Phase III Randomized Study of Vincristine, Dactinomycin, and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan Hydrochloride in Combination With Radiotherapy in Patients With Newly Diagnosed, Intermediate-Risk Rhabdomyosarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 50				NCI				COG-ARST0531 NCT00354835, ARST0531

Last Modified: 6/16/2006 First Published: 9/25/2004


7.		Phase I/II Study of Real Time Magnetic Resonance-Based Non-Invasive Thermometry in Patients With Grade 2 or 3 Soft Tissue Sarcoma of the Extremity Receiving Combination Hyperthermia, Radiotherapy, Surgery, and Optional Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				DUMC-1308-04-7R5 DUMC-G040102, DUMC-G880018, NCT00093509

Last Modified: 12/6/2007 First Published: 9/23/2005


8.		Phase I/II Study of Nelfinavir Mesylate in Patients With Recurrent, Metastatic, or Unresectable Liposarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				CHNMC-04090 NCT00233948


9.		Phase I/II Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Other				INST 0509C NCT00276055


10.		Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				10 and over				Pharmaceutical / Industry				A4021020 NCT00560235

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute